Rescue therapy in septic shock – is terlipressin the last frontier?

Use of terlipressin, an analogue of vasopressin, can be considered in septic shock patients with intractable hypotension and high cardiac output in whom fluid resuscitation and high-dose conventional catecholamines have failed. The effects of this agent on organ function are poorly evaluated in huma...

Descripción completa

Detalles Bibliográficos
Autores principales: Leone, Marc, Martin, Claude
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550872/
https://www.ncbi.nlm.nih.gov/pubmed/16584529
http://dx.doi.org/10.1186/cc4863
_version_ 1782129292972392448
author Leone, Marc
Martin, Claude
author_facet Leone, Marc
Martin, Claude
author_sort Leone, Marc
collection PubMed
description Use of terlipressin, an analogue of vasopressin, can be considered in septic shock patients with intractable hypotension and high cardiac output in whom fluid resuscitation and high-dose conventional catecholamines have failed. The effects of this agent on organ function are poorly evaluated in humans. The limited number of patients evaluated precludes any analysis of adverse outcomes and prognosis.
format Text
id pubmed-1550872
institution National Center for Biotechnology Information
language English
publishDate 2006
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-15508722006-08-22 Rescue therapy in septic shock – is terlipressin the last frontier? Leone, Marc Martin, Claude Crit Care Commentary Use of terlipressin, an analogue of vasopressin, can be considered in septic shock patients with intractable hypotension and high cardiac output in whom fluid resuscitation and high-dose conventional catecholamines have failed. The effects of this agent on organ function are poorly evaluated in humans. The limited number of patients evaluated precludes any analysis of adverse outcomes and prognosis. BioMed Central 2006 2006-03-21 /pmc/articles/PMC1550872/ /pubmed/16584529 http://dx.doi.org/10.1186/cc4863 Text en Copyright © 2006 BioMed Central Ltd
spellingShingle Commentary
Leone, Marc
Martin, Claude
Rescue therapy in septic shock – is terlipressin the last frontier?
title Rescue therapy in septic shock – is terlipressin the last frontier?
title_full Rescue therapy in septic shock – is terlipressin the last frontier?
title_fullStr Rescue therapy in septic shock – is terlipressin the last frontier?
title_full_unstemmed Rescue therapy in septic shock – is terlipressin the last frontier?
title_short Rescue therapy in septic shock – is terlipressin the last frontier?
title_sort rescue therapy in septic shock – is terlipressin the last frontier?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1550872/
https://www.ncbi.nlm.nih.gov/pubmed/16584529
http://dx.doi.org/10.1186/cc4863
work_keys_str_mv AT leonemarc rescuetherapyinsepticshockisterlipressinthelastfrontier
AT martinclaude rescuetherapyinsepticshockisterlipressinthelastfrontier

Ejemplares similares